4.5 Article

Genetic and pharmacological evidence of intraneuronal Aβ accumulation in APP transgenic mice

期刊

FEBS LETTERS
卷 583, 期 18, 页码 3021-3026

出版社

WILEY
DOI: 10.1016/j.febslet.2009.08.009

关键词

Amyloid precursor protein secretases; Amyloid beta protein; Bace1 protein, mouse; Immunohistochemistry; Intracellular space; Mice, transgenic

资金

  1. Uppsala University
  2. Land-stinge t i Uppsala lan
  3. The Swedish Brain Fund
  4. Bertil Hallstens Forskningsstiftelse
  5. Alzheimerfonden
  6. Demensfonden
  7. Gamla Tjnarinnor
  8. Gun och Bertil Stohnes Stiftelse
  9. Magnus Bergvall
  10. Ahlnsstiftelsen
  11. Lars Hierta
  12. Lundstroms Minne
  13. Frimurarstiftelsen
  14. Svenska Lakarsallskapet
  15. Swedish Research Council [2006-2822, 2006-2818]

向作者/读者索取更多资源

Intraneuronal punctate immunostaining in Alzheimer's disease brain and amyloid-beta precursor protein (APP) transgenic mice has been suggested to represent A beta, but this is somewhat controversial. Here we show that both biochemical A beta levels and intraneuronal immunostaining are reduced in APP transgenic mice when gamma-secretase is inhibited. Moreover, BACE-1 deficient APP transgenic mice show neither A beta production nor intraneuronal immunostaining. Our findings suggest that the punctate immunostaining with APP antibodies is due to A beta that has accumulated inside neurons. Similar type of intraneuronal A beta accumulation, which precedes senile plaque formation, may link A beta to tauopathy and neurodegeneration in Alzheimer's disease pathogenesis. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据